cbdMD, Inc. (YCBD)
2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-06-30 | |
|---|---|---|---|---|
| Total net sales | 4,606,796 | 4,749,426 | 5,113,476 | 5,173,878 |
| Cost of sales | 1,775,709 | 1,790,062 | 1,712,867 | 1,770,364 |
| Gross profit | 2,831,087 | 2,959,364 | 3,400,609 | 3,403,514 |
| Operating expenses | 3,735,773 | 3,445,180 | 3,486,881 | 3,785,542 |
| Loss from operations | -904,686 | -485,816 | -86,272 | -382,028 |
| Interest expense (income) | 9,414 | 7,642 | 11,404 | -12,741 |
| Decrease of contingent liability | - | - | - | - |
| Change in fair value of convertible notes | - | -2,583 | 89,963 | 854,506 |
| Loss before provision for income taxes | -895,272 | -480,757 | 15,095 | 459,737 |
| Net loss (income) | -895,272 | -480,757 | 15,095 | 459,737 |
| Preferred dividends | 333,500 | 1,000,500 | 1,000,501 | 1,000,500 |
| Net loss attributable to cbdmd, inc. common shareholders | -1,228,772 | -1,481,257 | -985,406 | -540,763 |
| Diluted eps | - | - | - | -0.15 |
| Basic and diluted earnings per share (in dollars per share) | -0.21 | -1.9 | -0.22 | -0.15 |
| Weighted average number of shares basic and diluted (in shares) | 5,783,354 | 778,410 | 4,552,067 | 3,592,969 |